Publications by authors named "Anna Verrone"

Claim this Profile
D
Drug survival, effectiveness and safety of risankizumab for moderate-to-severe psoriasis for up to 4 years.
Luca Mastorino, Paolo Dapavo, Michela Ortoncelli, Elena Stroppiana, Anna Verrone

Clin Exp Dermatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug survival, effectiveness and safety of guselkumab for moderate-to-severe psoriasis for up to 4 years.
Luca Mastorino, Paolo Dapavo, Michela Ortoncelli, Elena Stroppiana, Anna Verrone

Clin Exp Dermatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics and response to biological therapies for inverse psoriasis: a real-life comparison between the therapeutic effects of anti-IL-23 and anti-IL-17 agents.
Luca Mastorino, Paolo Dapavo, Nicole Macagno, Michela Ortoncelli, Anna Verrone

Int J Dermatol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug Survival and Clinical Course of Patients with Cancer Treated with Biologic Therapy for Psoriasis.
Nicole Macagno, Luca Mastorino, Michela Ortoncelli, Silvia Borriello, Chiara Astrua, Anna Verrone

J Clin Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug survival, effectiveness, and safety of brodalumab for moderate-to-severe psoriasis up to 3 years.
Luca Mastorino, Paolo Dapavo, Lorenza Burzi, Francois Rosset, Isotta Giunipero di Corteranzo, Anna Verrone

Int J Dermatol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug Survival, Safety, and Effectiveness of Secukinumab for up to 5 Years in Patients with Psoriasis and Psoriatic Arthritis: A Long-Term Real-Life Experience.
Luca Mastorino, Paolo Dapavo, Caterina Cariti, Sara Susca, Niccolò Siliquini, Anna Verrone

J Pers Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug survival and clinical effectiveness of secukinumab, ixekizumab, brodalumab, guselkumab, risankizumab, tildrakizumab for psoriasis treatment.
Luca Mastorino, Paolo Dapavo, Sara Susca, Caterina Cariti, Niccolò Siliquini, Anna Verrone

J Dtsch Dermatol Ges· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Superresponders" at biologic treatment for psoriasis: A comparative study among IL17 and IL23 inhibitors.
Luca Mastorino, Sara Susca, Caterina Cariti, Anna Verrone, Elena Stroppiana

Exp Dermatol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interclass Switch between IL17 and IL23 Inhibitors in Psoriasis: A Real-Life, Long-Term, Single-Center Experience.
Silvia Giordano, Paolo Dapavo, Michela Ortoncelli, Elena Stroppiana, Anna Verrone

J Clin Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical effectiveness of IL-17 and IL-23 inhibitors on difficult-to-treat psoriasis areas (scalp, genital, and palmoplantar sites): a retrospective, observational, single-center, real-life study.
Luca Mastorino, Lorenza Burzi, Giada Frigatti, Alessandra Fazio, Valentina Celoria, Anna Verrone

Expert Opin Biol Ther· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison between brodalumab, secukinumab and ixekizumab effectiveness and drug survival: A real-life experience on 638 patients with psoriasis.
Luca Mastorino, Caterina Cariti, Sara Susca, Niccolò Siliquini, Anna Verrone

Exp Dermatol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug survival and efficacy of anti-interleukin 23 biologics in psoriasis: a comparative study on different agents.
Gabriele Roccuzzo, Luca Mastorino, Sara Susca, Caterina Cariti, Stefania G Passerini, Anna Verrone

Clin Exp Dermatol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term proactive management of psoriasis with calcipotriol and betamethasone dipropionate foam: an Italian consensus through a combined nominal group technique and Delphi approach.
Clara De Simone, Paolo Dapavo, Piergiorgio Malagoli, Alessandro Martella, Anna Campanati, Anna Verrone

Int J Dermatol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tildrakizumab in real-life shows good efficacy in moderate-to-severe psoriasis regardless of previous use of biologic drugs and joint involvement.
Luca Mastorino, Caterina Cariti, Sara Susca, Nadia Sciamarrelli, Silvia Borriello, Anna Verrone

Dermatol Ther· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, safety, and drug survival of IL-23, IL-17, and TNF-alpha inhibitors for psoriasis treatment: a retrospective study.
Paolo Dapavo, Niccolò Siliquini, Luca Mastorino, Gianluca Avallone, Martina Merli, Anna Verrone

J Dermatolog Treat· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of switching from adalimumab originator to adalimumab biosimilar in moderate to severe psoriasis patients: A Real-life experience in a tertiary referral centre.
Giuseppe Gallo, Elisabetta Rostagno, Niccolò Siliquini, Elena Stroppiana, Anna Verrone

Australas J Dermatol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gender differences in genital lichen sclerosus: data from a multicenter Italian study on 729 consecutive cases.
Annarosa Virgili, Alessandro Borghi, Simone Cazzaniga, Anna Di Landro, Luigi Naldi, Anna Verrone

G Ital Dermatol Venereol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels?
Lucia Carulli, Stefano Ballestri, Amedeo Lonardo, Francesca Lami, Enrico Violi, Anna Maria Verrone

Intern Emerg Med· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
O6-methylguanine-DNA methyltransferase promoter hypermethylation in colorectal carcinogenesis.
Mirco Menigatti, Monica Pedroni, Anna Maria Verrone, Francesca Borghi, Alessandra Scarselli

Oncol Rep· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: prevalence and correlates.
Paola Loria, Amedeo Lonardo, Francesca Leonardi, Cristina Fontana, Lucia Carulli, Anna Maria Verrone

Dig Dis Sci· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis